HYPOKALEMIA BLUNTS LEFT VENTRICULAR MASS REGRESSION IN HYPERTENSIVE PATIENTS DURING LOSARTAN- OR ATENOLOL-BASED TREATMENT: THE LIFE ECHO-SUBSTUDY

被引：0
|
作者：
Chinali, M. [1 ]
Aurigemma, G. P. [1 ]
Okin, P. M. [2 ]
Gerdts, E. [3 ]
Wachtell, K. [4 ]
Kjeldsen, S. E. [5 ]
Julius, S. [6 ]
Dalhof, B. [7 ]
de Simone, G. [8 ]
Devereux, R. B. [2 ]
机构：
[1] Univ Massachusetts, Sch Med, Worcester, MA USA
[2] Weill Cornell Med Coll, New York, NY USA
[3] Haukeland Hosp, N-5021 Bergen, Norway
[4] Rigshosp, DK-2100 Copenhagen, Denmark
[5] Univ Oslo, Oslo, Norway
[6] Univ Michigan, Ann Arbor, MI 48109 USA
[7] Sahlgrens Univ Hosp, Gothenburg, Sweden
[8] Federico II Univ Hosp, Naples, Italy
来源：
JOURNAL OF HYPERTENSION | 2010年 / 28卷
关键词：
D O I：
10.1097/01.hjh.0000379531.51584.03
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：E442 / E443
页数：3
相关论文
共 50 条
  • [41] Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy?: The LIFE study
    Ibsen, H
    Olsen, MH
    Wachtell, K
    Borch-Johnsen, K
    Lindholm, LH
    Mogensen, CE
    Dahlöf, B
    Snapinn, SM
    Wan, Y
    Lyle, PA
    [J]. DIABETES CARE, 2006, 29 (03) : 595 - 600
  • [42] Older age does not attenuate hypertrophy regression during antihypertensive treatment in hypertensive patients with left ventricular hypertrophy (the LIFE study)
    Gerdts, E
    Roman, MJ
    Palmieri, V
    Smith, G
    Wachtell, K
    Nieminen, MS
    Dahlöf, B
    Devereux, RB
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (05) : 87A - 87A
  • [43] Economic evaluation of losartan compared with atenolol in the treatment of hypertension with left ventricular hypertrophy: A cost-minimization analyisis based on life study
    Chevreul, K
    Durand-Zaleski, I
    Souchet, T
    [J]. VALUE IN HEALTH, 2003, 6 (03) : 317 - 318
  • [44] Economic evaluation of losartan compared with atenolol in the treatment of hypertension with left ventricular hypertrophy: Cost-minimization analysis based on LIFE study
    Chevreul, K
    Durand-Zaleski, I
    Souchet, T
    [J]. VALUE IN HEALTH, 2003, 6 (06) : 666 - 666
  • [45] Does Losartan improve diastolic left ventricular function better than atenolol during more than four years of antihypensive treatment?: The LIFE study
    Wachtell, K
    Gerdts, E
    Palmieri, V
    Bella, JN
    Olsen, MH
    Rokkedal, J
    Boman, K
    Lasarett, S
    Smith, G
    Dahlöf, B
    Devereux, RB
    [J]. CIRCULATION, 2004, 110 (17) : 637 - 637
  • [46] Prognostic value of left ventricular mass and its evolution during treatment in the Bordeaux cohort of hypertensive patients
    Cipriano, C
    Gosse, P
    Bemurat, L
    Mas, D
    Lemetayer, P
    N'Tela, G
    Clementy, J
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2001, 14 (06) : 524 - 529
  • [47] Inappropriate left ventricular mass changes during treatment adversely affects cardiovascular prognosis in hypertensive patients
    Muiesan, Maria Lorenza
    Salvetti, Massimo
    Paini, Anna
    Monteduro, Cristina
    Galbassini, Gloria
    Bonzi, Bianca
    Poisa, Paolo
    Belotti, Eugenia
    Rosei, Claudia Agabiti
    Rizzoni, Damiano
    Castellano, Maurizio
    Rosei, Enrico Agabiti
    [J]. HYPERTENSION, 2007, 49 (05) : 1077 - 1083
  • [48] Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients:: The Losartan Intervention For Endpoint Reduction (LIFE) study
    Oikarinen, L
    Nieminen, MS
    Toivonen, L
    Viitasalo, M
    Wachtell, K
    Papademetriou, V
    Jern, S
    Dahlöf, B
    Devereux, RB
    Okin, PM
    [J]. AMERICAN HEART JOURNAL, 2003, 145 (05) : 919 - 925
  • [49] Competing Effects of Hypokalemia and Hydrochlorothiazide Treatment on Regression of Cornell Product Left Ventricular Hypertrophy in Hypertensive Patients: Implications for Development of Potassium-Sparing Diuretics
    Okin, Peter M.
    Kjeldsen, Sverre
    Lindholm, Lars H.
    Dahlof, Bjorn
    Devereux, Richard B.
    [J]. CIRCULATION, 2009, 120 (18) : S1015 - S1015
  • [50] Effects of spironolactone during an angiotensin II receptor blocker treatment on the left ventricular mass reduction in hypertensive patients with concentric left ventricular hypertrophy
    Taniguchi, Ikuo
    Kawai, Makoto
    Date, Taro
    Yoshida, Satoru
    Seki, Shingo
    Taniguchi, Masayuki
    Shimizu, Mitsuyuki
    Mochizuki, Seibu
    [J]. CIRCULATION JOURNAL, 2006, 70 (08) : 995 - 1000
12345